424 Ergebnisse für: signaling
-
Carsten Watzl OR Carsten Scaffidi - Google Scholar Citations
https://scholar.google.de/citations?user=FvbsFaQAAAAJ&hl=de
Keine Beschreibung vorhanden.
-
Joseph Schlessinger - Google Scholar Citations
https://scholar.google.de/citations?user=L7vygrQAAAAJ&hl=de&oi=ao
Keine Beschreibung vorhanden.
-
Signal Transduction/Proteomics Laboratory - Medizinische Universität Innsbruck
https://www.i-med.ac.at/cellbio/labore/sigtranslab/index.html.de
Keine Beschreibung vorhanden.
-
Mitochondrial.co.de - Ihr Mitochondrial Shop
http://www.mitochondrial.co.de
Living Well with Mitochondrial Disease als eBook Download von Cristy Balcells, Veränderungen der mitochondrialen Funktion bei Tauopathien als Buch von Kathrin Schulz, Cellular and Molecular Basis of Mitochondrial Inheritance, Molecular Biology of…
-
Category:Pheromones – Wikimedia Commons
https://commons.wikimedia.org/wiki/Category:Pheromones?uselang=de
Keine Beschreibung vorhanden.
-
GEB - A-kinase anchoring proteins AKAP1, -4, -10 and -11 with different subcellular localizations in Sertoli cells and their roles in male fertility - Wang, Wenwen
http://geb.uni-giessen.de/geb/volltexte/2016/12075/index.html
OPUS Version 3.2
-
Men’s and Women’s Immune Systems Respond Differently to PTSD
http://www.innovations-report.de/html/berichte/biowissenschaften_chemie/men_s_women_s_immune_systems_respond_differently_174287.
Keine Beschreibung vorhanden.
-
Category:Growth factors – Wikimedia Commons
https://commons.wikimedia.org/wiki/Category:Growth_factors?uselang=de
Keine Beschreibung vorhanden.
-
Mycobacterium: Genomics and Molecular Biology - Google Books
https://books.google.de/books?id=2UFkCKT6K8sC&pg=PA24#v=onepage
In this book, expert scientists critically review the current and most recent advances in the genomics and molecular biology of mycobacteria. With the focus being on the topical and most relevant aspects, the contributors provide insight into the current…
-
Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer and other malignant diseases
http://apogenix.de/unternehmensfuehrung/beirat/
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.